About St James' Hospital; Cancer Clinical Trials Office
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Clinical Trials at St James' Hospital; Cancer Clinical Trials Office
During the past decade, St James' Hospital; Cancer Clinical Trials Office conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Vemurafenib in Participants With Metastatic Melanoma
2011-03-01
2016-02-24
Completed
3,219
A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma
2012-08-24
2016-09-16
Completed
572
A Study to Evaluate the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab, Gemcitabine and Oxaliplatin Compared to Rituximab, Gemcitabine and Oxaliplatin Alone in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
2020-02-07
2025-12-31
Recruiting
260
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at St James' Hospital; Cancer Clinical Trials Office
According to Clinical.Site data, the most researched conditions in "St James' Hospital; Cancer Clinical Trials Office" are
"Diffuse Large B-Cell Lymphoma" (1 trials), "Lymphoma, Large B-Cell, Diffuse" (1 trials), "Malignant Melanoma" (1 trials) and "Tumors" (1 trials). Many other conditions were trialed in "St James' Hospital; Cancer Clinical Trials Office" in a lesser frequency.
Clinical Trials Intervention Types at St James' Hospital; Cancer Clinical Trials Office
Most popular intervention types in "St James' Hospital; Cancer Clinical Trials Office" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (PD-L1) antibody" (1 trials), "CHOP" (1 trials), "Gemcitabine" (1 trials), "Oxaliplatin" (1 trials) and "Polatuzumab Vedotin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at St James' Hospital; Cancer Clinical Trials Office
The vast majority of trials in "St James' Hospital; Cancer Clinical Trials Office" are
4 trials for "All" genders.
Clinical Trials Status at St James' Hospital; Cancer Clinical Trials Office
Currently, there are NaN active trials in "St James' Hospital; Cancer Clinical Trials Office".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in St James' Hospital; Cancer Clinical Trials Office,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in St James' Hospital; Cancer Clinical Trials Office, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".